INBS - Intelligent Bio Solutions Inc. News

Intelligent Bio Solutions Registers 6,211,809 Shares Of Common Stock For Resale Underlying Warrants

INTELLIGENT BIO SOLUTIONS INC. 6,211,809 Shares of Common Stock Pursuant to this prospectus, the sel

Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET

Management to discuss FDA 510(k) submission, clinical data, and commercial progress outside the U.S.

Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market

Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screen

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening S

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” o

12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-mar

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday

UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Pr

Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical te

Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical te

Intelligent Bio Solutions Commences ~$M Placement Of Common Shares, Warrants At Combined Price Of $2

Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical t

Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned

Multi-site clinical study delivers strong performance data for Intelligent Fingerprinting Drug Scree

Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Inst

$5 Million Upfront at Closing and $5 Million Tranche Warrant Callable by the Company Following FDA 5

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday&#3

BlackRock Inc. Invests $149.96 Million in Intelligent Bio Solutions Inc. $INBS

BlackRock Inc. purchased a new stake in shares of Intelligent Bio Solutions Inc. (NASDAQ: INBS) duri

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular s

Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven

Reader installed base grew 22% year-over-year, driving a 35% increase in total consumable cartridges

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?

Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) are surging Monday afternoon after the medica

Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action?

Shares of Intelligent Bio Solutions are surging Monday after it announced a significant regulatory m

Intelligent Bio Solutions' Intelligent Fingerprinting Drug Screening Business Has Been ISO Recertifi

The recertification, issued by the British Standards Institution (BSI), is effective October 14, 202

Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification

Recertification aligns with the FDA's newly amended Quality Management System Regulation and support

12 Health Care Stocks Moving In Wednesday's Intraday Session

Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular sess

Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Finger

NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or

Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening Sy

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical t

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or

Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances o

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular sessio

Comparing Eurofins Scient (OTCMKTS:ERFSF) & Intelligent Bio Solutions (NASDAQ:INBS)

Intelligent Bio Solutions (NASDAQ: INBS - Get Free Report) and Eurofins Scient (OTCMKTS:ERFSF - Get

Intelligent Bio Solutions Resolves All Cybersecurity, Software-Related Review Items For Its Upcoming

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical t

Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing T

Company has addressed final review items from penetration testing and finalized cybersecurity and so

Intelligent Bio Solutions Completes Precision Testing For Its Intelligent Fingerprinting Drug Screen

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical t

Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package A

Precision testing confirms reproducibility across more than 1,600 tests, three production runs, and

Intelligent Bio Solutions Starts Interference Study To Support FDA Submission For U.S. Market Cleara

The Company has again partnered with CenExel Clinical Research, Inc. to complete the clinical study.

Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market

Interference Study designed to validate system specificity in the presence of potentially interferin

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or

Intelligent Bio Solutions Initiates Multi-Site Method Comparison Study To Support FDA 510(k) Submiss

Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerpr

Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission

Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerpr

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Intelligent Bio Solutions Q3 EPS $(1.80) Up From $(4.40) YoY, Sales $1.060M Up From $728.867K YoY

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(1.80) per share. This is a 59

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, repres

12 Health Care Stocks Moving In Monday's Intraday Session

Comparing Establishment Labs (NASDAQ:ESTA) & Intelligent Bio Solutions (NASDAQ:INBS)

Establishment Labs (NASDAQ: ESTA - Get Free Report) and Intelligent Bio Solutions (NASDAQ: INBS - Ge

Aeon Global Health (OTCMKTS:AGHC) vs. Intelligent Bio Solutions (NASDAQ:INBS) Head-To-Head Review

Aeon Global Health (OTCMKTS:AGHC - Get Free Report) and Intelligent Bio Solutions (NASDAQ: INBS - Ge

Intelligent Bio Solution Launches Validation Study Targeting A Significant Reduction In The Time Req

The study aims to improve the already rapid time-to-result of INBS's drug screening technology,

Intelligent Bio Solutions Completes Penetration Testing As Part Of Its Upcoming FDA Submission

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical t

Intelligent Bio Solutions Completes Its Initial Clinical Cut-Off Trial For FDA 510(k) Submission For

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical t

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Intelligent Bio Solutions Partners With Bouygues UK For Deployment Of INBS's Fingerprint Drug Screen

Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical te

Intelligent Bio Solutions Q2 EPS $(2.82) Up From $(4.96) YoY, Sales $896.774K Up From $607.494K YoY

Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(2.82) per share. This is a 43

Intelligent Bio Solutions Commences Clinical Studies To Support FDA 510(k) Submission For U.S. Marke

Clinical studies designed to support FDA clearance and planned commercial launch into the world'